Sensus Healthcare to Present at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

On September 9, 2022, Sensus Healthcare (Nasdaq: SRTS) announced its participation in the H.C. Wainwright 24^th Annual Global Investment Conference, scheduled for September 12-14, 2022, in New York City. Management will deliver a company overview and conduct one-on-one meetings with investors. A webcast of the presentation will be accessible on-demand starting September 12, 2022, at 7:00 a.m. ET on Sensus Healthcare’s website. The company specializes in innovative, non-invasive treatments for various conditions, particularly using its proprietary superficial radiation therapy technology.

BOCA RATON, Fla., Sept. 09, 2022 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally invasive and cost-effective treatments for oncological and non-oncological conditions, announces that management will present a company overview at the H.C. Wainwright 24^th Annual Global Investment Conference being held September 12-14, 2022.  The hybrid format includes in-person meetings in New York City and will be holding one-on-one meetings.  A webcast of the presentation will be available on-demand beginning September 12, 2022 at 7:00 a.m. Eastern time on the investors section of Sensus Healthcare’s website or at this link.

Joe Sardano, chief executive officer, Javier Rampolla, chief financial officer, and Michael Sardano, president and general counsel, will be available during the conference for 1x1 meetings with the investment community on site at the Lotte New York Palace Hotel.

About Sensus Healthcare

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for both oncological and non-oncological conditions. Sensus offers its proprietary low-energy X-ray technology known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100^™, SRT-100+^™ and SRT-100 Vision^™ systems. With its portfolio of innovative medical device products, including aesthetic lasers and its needleless TransDermal Infusion System^™, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.  For more information, visit www.sensushealthcare.com.

Contact:
LHA Investor Relations
Kim Sutton Golodetz
212-838-3777
kgolodetz@lhai.com

#   #   #

FAQ

What is Sensus Healthcare's upcoming event related to SRTS?

Sensus Healthcare will present at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022.

Where will the H.C. Wainwright 24th Annual Global Investment Conference take place?

The conference will be held in New York City.

What date will the Sensus Healthcare presentation be available on-demand?

The Sensus Healthcare presentation will be available on-demand starting September 12, 2022, at 7:00 a.m. Eastern Time.

Who are the executives presenting for Sensus Healthcare at the conference?

Executives Joe Sardano, Javier Rampolla, and Michael Sardano will represent Sensus Healthcare at the conference.

What technology does Sensus Healthcare specialize in?

Sensus Healthcare specializes in non-invasive treatments using proprietary superficial radiation therapy technology.